BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 20974822)

  • 21. Future perspectives, applications and challenges of genomic epidemiology studies for food-borne pathogens: A case study of Enterohemorrhagic Escherichia coli (EHEC) of the O157:H7 serotype.
    Eppinger M; Cebula TA
    Gut Microbes; 2015; 6(3):194-201. PubMed ID: 25483335
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic use of a receptor mimic probiotic reduces intestinal Shiga toxin levels in a piglet model of hemolytic uremic syndrome.
    Hostetter SJ; Helgerson AF; Paton JC; Paton AW; Cornick NA
    BMC Res Notes; 2014 Jun; 7():331. PubMed ID: 24890228
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of Direct-Fed Microbial Dosage on the Fecal Concentrations of Enterohemorrhagic Escherichia coli in Feedlot Cattle.
    Luedtke BE; Bosilevac JM; Harhay DM; Arthur TM
    Foodborne Pathog Dis; 2016 Apr; 13(4):190-5. PubMed ID: 26974651
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Probiotic and enterohemorrhagic Escherichia coli: An effective strategy against a deadly enemy?
    Cordonnier C; Thévenot J; Etienne-Mesmin L; Alric M; Livrelli V; Blanquet-Diot S
    Crit Rev Microbiol; 2017 Feb; 43(1):116-132. PubMed ID: 27798976
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Histamine H2 Receptor-Mediated Suppression of Intestinal Inflammation by Probiotic Lactobacillus reuteri.
    Gao C; Major A; Rendon D; Lugo M; Jackson V; Shi Z; Mori-Akiyama Y; Versalovic J
    mBio; 2015 Dec; 6(6):e01358-15. PubMed ID: 26670383
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Feed Fermentation with Reuteran- and Levan-Producing Lactobacillus reuteri Reduces Colonization of Weanling Pigs by Enterotoxigenic Escherichia coli.
    Yang Y; Galle S; Le MH; Zijlstra RT; Gänzle MG
    Appl Environ Microbiol; 2015 Sep; 81(17):5743-52. PubMed ID: 26070673
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enterohemorrhagic Escherichia coli suppresses inflammatory response to cytokines and its own toxin.
    Bellmeyer A; Cotton C; Kanteti R; Koutsouris A; Viswanathan VK; Hecht G
    Am J Physiol Gastrointest Liver Physiol; 2009 Sep; 297(3):G576-81. PubMed ID: 19556613
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of a multiplex PCR assay for detection of Shiga toxin-producing Escherichia coli, enterohemorrhagic E. coli, and enteropathogenic E. coli strains.
    Botkin DJ; Galli L; Sankarapani V; Soler M; Rivas M; Torres AG
    Front Cell Infect Microbiol; 2012; 2():8. PubMed ID: 22919600
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Salmonella enterica serovar Typhimurium vaccine strains expressing a nontoxic Shiga-like toxin 2 derivative induce partial protective immunity to the toxin expressed by enterohemorrhagic Escherichia coli.
    Rojas RL; Gomes PA; Bentancor LV; Sbrogio-Almeida ME; Costa SO; Massis LM; Ferreira RC; Palermo MS; Ferreira LC
    Clin Vaccine Immunol; 2010 Apr; 17(4):529-36. PubMed ID: 20147499
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytokine profiles of patients with enterohemorrhagic Escherichia coli O111-induced hemolytic-uremic syndrome.
    Shimizu M; Kuroda M; Sakashita N; Konishi M; Kaneda H; Igarashi N; Yamahana J; Taneichi H; Kanegane H; Ito M; Saito S; Ohta K; Taniguchi T; Furuichi K; Wada T; Nakagawa M; Yokoyama H; Yachie A
    Cytokine; 2012 Dec; 60(3):694-700. PubMed ID: 22929411
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interleukin-33/ST2 signaling contributes to the severity of hemolytic uremic syndrome induced by enterohemorrhagic Escherichia coli.
    Yamada S; Shimizu M; Kuroda M; Inoue N; Sugimoto N; Yachie A
    Clin Exp Nephrol; 2019 Apr; 23(4):544-550. PubMed ID: 30467800
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A naturally occurring rabbit model of enterohemorrhagic Escherichia coli-induced disease.
    García A; Marini RP; Feng Y; Vitsky A; Knox KA; Taylor NS; Schauer DB; Fox JG
    J Infect Dis; 2002 Dec; 186(11):1682-6. PubMed ID: 12447748
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In Vitro Evaluation of Swine-Derived Lactobacillus reuteri: Probiotic Properties and Effects on Intestinal Porcine Epithelial Cells Challenged with Enterotoxigenic Escherichia coli K88.
    Wang Z; Wang L; Chen Z; Ma X; Yang X; Zhang J; Jiang Z
    J Microbiol Biotechnol; 2016 Jun; 26(6):1018-25. PubMed ID: 26907754
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Secretion of Recombinant Interleukin-22 by Engineered Lactobacillus reuteri Reduces Fatty Liver Disease in a Mouse Model of Diet-Induced Obesity.
    Oh JH; Schueler KL; Stapleton DS; Alexander LM; Yen CE; Keller MP; Attie AD; van Pijkeren JP
    mSphere; 2020 Jun; 5(3):. PubMed ID: 32581074
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of EHEC gold nanoparticle vaccines evaluated with the Shiga toxin-producing
    Bowser S; Melton-Celsa A; Chapartegui-González I; Torres AG
    Microbiol Spectr; 2024 Jan; 12(1):e0226123. PubMed ID: 38047703
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ultrasound findings in EHEC-associated hemolytic-uremic syndrome and their clinical relevance.
    Reising A; Hafer C; Hiss M; Kielstein JT; Menne J; Gueler F; Beneke J; Linnenweber-Held S; Haller H; Einecke G
    Int Urol Nephrol; 2016 Apr; 48(4):561-70. PubMed ID: 26759326
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Shiga toxin-mediated hemolytic uremic syndrome: time to change the diagnostic paradigm?
    Bielaszewska M; Köck R; Friedrich AW; von Eiff C; Zimmerhackl LB; Karch H; Mellmann A
    PLoS One; 2007 Oct; 2(10):e1024. PubMed ID: 17925872
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Infection due to Shiga toxin-producing enterohemorrhagic
    Tanquilut CD; Jung CW; Nelson AW; Lau SK
    IDCases; 2019; 18():e00629. PubMed ID: 31528540
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional properties of free and encapsulated Lactobacillus reuteri DPC16 during and after passage through a simulated gastrointestinal tract.
    Zhao Q; Mutukumira A; Lee SJ; Maddox I; Shu Q
    World J Microbiol Biotechnol; 2012 Jan; 28(1):61-70. PubMed ID: 22806780
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum insulin-like growth factor-binding protein 2 levels as an indicator for disease severity in enterohemorrhagic
    Tasaki Y; Inoue N; Shimizu M; Sugimoto N; Ishikawa S; Mizuta M; Yokoyama T; Kuroda M; Ohta K; Yachie A; Wada T
    Ren Fail; 2021 Dec; 43(1):382-387. PubMed ID: 33641616
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.